FDA Will Launch Its Opioid Data Warehouse In March

In March, FDA’s newly established Controlled Substances Program will launch its Opioid Data Warehouse, which will allow the agency to integrate diverse data sources and enhance data analysis to pinpoint trends and new developments in the opioid crisis, FDA Deputy Center Director for Regulatory Programs Doug Throckmorton said Wednesday (Feb. 12). The agency also is considering a framework to be laid out in a draft guidance on developing medication-assisted treatment for stimulant use disorder. In an email sent to drug...